The role of basiliximab in the evolving renal transplantation immunosuppression protocol

Basiliximab is a chimeric mouse-human monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor on activated T lymphocytes. It was shown in phase III trials to reduce the number and severity of acute rejection episodes in the first year following renal transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Salis, Paola, Caccamo, Chiara, Verzaro, Roberto, Gruttadauria, Salvatore, Artero, Mary
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721359/
https://www.ncbi.nlm.nih.gov/pubmed/19707352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721359/
https://www.ncbi.nlm.nih.gov/pubmed/19707352

Ejemplares similares